Tokyo, May 1 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061408) titled 'A Prospective Study Investigating Predictability and Discrepancies in Initial Tacrolimus Dosing Using Genetic Information' on May 1.
Study Type:
Observational
Primary Sponsor:
Institute - Shonan Kamakura General Hospital, Tokushukai Medical Corporation
Condition:
Condition - Immunosuppressive therapy (tacrolimus dosing) in kidney transplant recipients
Classification by malignancy - Others
Genomic information - YES
Objective:
Narrative objectives1 - The objective of this study is to characterize discrepancies between predicted and observed tacrolimus concentrations in a CYP3A5 genotype-based initial dosing model and...